TLDR: Stablecoin market cap hit $320B in Q1 2026, with monthly transfer volumes peaking at $1.8T. Systemic leverage compressed to…
TLDR: Trident’s RLUSD Ghana pilot targets 2.1M MSMEs with faster settlement and lower transfer friction. The rollout adds RLUSD/GHS liquidity…
Iran may charge crypto tolls at Strait of Hormuz. Analysts weigh in on Bitcoin vs stablecoins and compliance risks for global shipping companies.
Bhutan has sold 70% of its Bitcoin reserves since October 2024, moving over $233M in 2026. Mining operations appear halted as holdings drop to 3,774 BTC.
Bittensor (TAO) plummeted 30% after Covenant AI exited, alleging centralized control by co-founder. Analysis shows risk of further 45% decline ahead.
Ethereum (ETH) holds $2,200+ after setting 3 records: 30% staking ratio ATH, 1.3M+ transfers, and $2.2B open interest spike. US demand rising via ETFs.
Latest News
View MoreTLDR: Aave Labs secured SOC 2 Type II for security, availability, and confidentiality controls across…
TLDR Bitcoin exchange netflow dropped to -$582 million within two days. Exchange reserves declined by…
TLDR Dom Kwok said XRP growth now extends beyond the SWIFT comparison narrative. Ripple focuses…
TLDR WLFI price declined 14% to $0.08 within 24 hours. Market capitalization dropped by $427…
TLDR Justin Sun’s frozen WLFI holdings lost over $11 million in 24 hours. WLFI price…
TLDR BitFuFu produced 214 BTC in March while selling 80 BTC from its treasury. The…
TLDR Hong Kong Monetary Authority issued its first stablecoin licences to Anchorpoint and HSBC Hong…
TLDR Ethereum gained 7.12% in March 2026 while Bitcoin rose 1.83%. Ethereum market cap increased…
TLDR Flare plans to reduce FLR inflation from 5% to 3% under a new governance…
FICO stock plummeted 13% Friday after Senator Josh Hawley launched a pricing investigation and Barclays cut its price target amid AI competition concerns.
FICO stock crashed 13% Friday after Senator Hawley launched a pricing investigation and Barclays cut its target, pushing shares to their lowest since 2023.
Replimune (REPL) stock plunged 19% after FDA rejected RP1 melanoma treatment for the second time, citing trial design issues. Trading halted twice.
Finance News
View MoreTLDR Dom Kwok said XRP growth now extends beyond the SWIFT comparison narrative. Ripple focuses…
TLDR WLFI price declined 14% to $0.08 within 24 hours. Market capitalization dropped by $427…
TLDR Justin Sun’s frozen WLFI holdings lost over $11 million in 24 hours. WLFI price…
TLDR Hong Kong Monetary Authority issued its first stablecoin licences to Anchorpoint and HSBC Hong…
TLDR Flare plans to reduce FLR inflation from 5% to 3% under a new governance…
FICO stock plummeted 13% Friday after Senator Josh Hawley launched a pricing investigation and Barclays cut its price target amid AI competition concerns.
FICO stock crashed 13% Friday after Senator Hawley launched a pricing investigation and Barclays cut its target, pushing shares to their lowest since 2023.
Replimune (REPL) stock plunged 19% after FDA rejected RP1 melanoma treatment for the second time, citing trial design issues. Trading halted twice.
Replimune (REPL) stock crashed 19% after FDA rejected RP1 melanoma treatment for second time, citing trial design issues. Shares fell to $4.76.
TLDR: Japan lifted Rapidus backing to $16.3B as its 2nm AI chip production deadline remains fixed for 2027.…
TLDR: CZ abandoned FTX rescue talks after SBF’s team failed…
TLDR: Aave Labs secured SOC 2 Type II for security, availability, and confidentiality controls…

















